NCIC-Clinical Trials Group

Kingston, Ontario K7L 3N6

0 studies enrolling now · 10 studies all time

What they study most

Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Sarcoma

Studies at this site

• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer — Stopped early
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer — Stopped early
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer — Completed
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix — Completed
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy — Completed
• Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer — Stopped early
• Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer — Completed
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer — Stopped early
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus — Stopped early